Feasibility of Allogeneic Hematopoietic Stem Cell Transplantation for Autoimmune Disease: Position Statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005

被引：49

作者：

Griffith, LM

Pavletic, SZ

Tyndall, A

Bredeson, CN

Bowen, JD

Childs, RW

Gratwohl, A

van Laar, JM

Mayes, MD

Martin, R

McSweeney, PA

Muraro, PA

Openshaw, H

Saccardi, R

Sandmaier, BM

Forman, SJ

Nash, RA

机构：

[1] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA

[2] NCI, Expt Transplant & Immunol Branch, NIH, Bethesda, MD 20892 USA

[3] Dept Rheumatol, Basel, Switzerland

[4] Med Coll Wisconsin, Ctr Int Blood & Marrow Transplantat Res, Milwaukee, WI 53226 USA

[5] Univ Washington, Dept Neurol, Seattle, WA 98195 USA

[6] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA

[7] Univ Basel, Dept Hematol, Kantonsspital, Basel, Switzerland

[8] Univ Basel, Dept Internal Med, Kantonsspital, Basel, Switzerland

[9] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands

[10] Univ Texas, Houston Hlth Sci Ctr, Dept Med, Div Rheumatol, Houston, TX USA

[11] Natl Inst Neurol Disorders & Stroke, Neuroimmunol Branch, Rocky Mtn Canc Ctr, NIH, Bethesda, MD USA

[12] City Hope Natl Med Ctr, Dept Neurol, Duarte, CA 91010 USA

[13] Policlin Careggi, Bone Marrow Transplant Unit, Florence, Italy

[14] Univ Washington, Seattle, WA 98195 USA

[15] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA

[16] City Hope Natl Med Ctr, Div Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

来源：

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 11期

关键词：

allogeneic hematopoietic cell transplantation; autoimmune disease; clinical trial;

D O I：

10.1016/j.bbmt.2005.07.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：862 / 870

页数：9

共 60 条

[1] Long-term outcome after bone marrow transplantation for severe aplastic anemia [J].

Ades, L ;

Mary, JY ;

Robin, M ;

Ferry, C ;

Porcher, R ;

Esperou, H ;

Ribaud, P ;

Devergie, A ;

Traineau, R ;

Gluckman, E ;

Socié, G .

BLOOD, 2004, 103 (07) :2490-2497

[2] Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials [J].

al-Jurf, M ;

Aranha, F ;

Annassetti, C ;

Apperley, JF ;

Baynes, R ;

Bensinger, WI ;

Blaise, D ;

Chaudhary, MA ;

Clarke, M ;

Cornelissen, JJ ;

Couban, S ;

Cutler, C ;

Djulbegovic, B ;

Gyger, M ;

Gratwohl, A ;

Heldal, D ;

Van der Holt, B ;

Hozo, I ;

Kuentz, M ;

Kumar, A ;

Lipton, J ;

Matchamm, J ;

Mohty, M ;

Morton, J ;

Panzarella, T ;

Powles, R ;

Richards, SM ;

Sahovic, E ;

Schmitz, N ;

Simpson, DR ;

Sirohi, B ;

Soares, HP ;

de Souza, CA ;

Vigorito, AC ;

Wheatley, K .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5074-5087

[3] Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: Recommendations from a Workshop at the 2001 Tandem Meetings [J].

Antin, JH ;

Childs, R ;

Filipovich, AH ;

Giralt, S ;

Mackinnon, S ;

Spitzer, T ;

Weisdorf, D .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2001, 7 (09) :473-485

[4] BONE-MARROW TRANSPLANTATION [J].

ARMITAGE, JO .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (12) :827-838

[5] High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation [J].

Baron, F ;

Maris, MB ;

Storer, BE ;

Sandmaier, BM ;

Panse, JP ;

Chauncey, TR ;

Sorror, M ;

Little, MT ;

Maloney, DG ;

Storb, R ;

Heimfeld, S .

LEUKEMIA, 2005, 19 (05) :822-828

[6] Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning [J].

Baron, F ;

Little, MT ;

Storb, R .

BLOOD REVIEWS, 2005, 19 (03) :153-164

[7] Development of biomarkers in multiple sclerosis [J].

Bielekova, B ;

Martin, R .

BRAIN, 2004, 127 :1463-1478

[8] Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer [J].

Bishop, MR ;

Fowler, DH ;

Marchigiani, D ;

Castro, K ;

Kasten-Sportes, C ;

Steinberg, SM ;

Gea-Banacloche, JC ;

Dean, R ;

Chow, CK ;

Carter, C ;

Read, EJ ;

Leitman, S ;

Gress, R .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (19) :3886-3892

[9] Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease [J].

Bredeson, CN ;

Pavletic, SZ .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (02) :327-343

[10] Trends in survival and cause of death in Danish patients with multiple sclerosis [J].

Bronnum-Hansen, H ;

Koch-Henriksen, N ;

Stenager, E .

BRAIN, 2004, 127 :844-850

← 1 2 3 4 5 6 →